Education

Gain a succinct overview of specific topics relating to every day practice with our wide range of education modules and advanced courses; quick and easy to complete anytime, anywhere. You will receive a certificate for completing any of these education activities. CPD points are also available. Our advanced courses provide the opportunity to develop indepth knowledge, skills, behaviour and attitudes in a range of therapeutic areas.

On-demand webinar - The opioid dependence treatment landscape is changing: What every GP needs to know

In this on-demand webinar we explore the new era in opioid dependence treatment and unpack the implications of these transformative changes, highlighting how they democratise access to treatments, including long-acting injectable buprenorphine (LAIB). While LAIBs play a critical role, they are part of a broader treatment landscape.

Mild cognitive impairment: What impact can GPs have by acting early?

Hours: 1 | EA: 1 | MO: 0 | RP: 0

Mild cognitive impairment (MCI) is an increasingly prevalent condition in Australia, and GPs can play a key role in its identification and management through early diagnosis and action. This module explores how to identify risk factors and make a diagnosis of MCI, and outlines the effective development of treatment plans for MCI in primary care.

Practice points: Keeping up with antiviral treatments for COVID-19 management in the community: an interactive conversation

Hours: 1 | EA: 0.5 | MO: 0 | RP: 0.5

Develop a practical understanding of the evolving role of oral antiviral therapy in the management of COVID-19 in this brand new education activity, with an opportunity to review your knowledge through a series of case studies.

On-demand MEDTalks: Navigating the changing landscape of pneumococcal disease in Australia

On-demand MEDTalks | Hours: 1 | EA: 1

Across four short, sharp and topical MEDTalks, a vibrant, passionate panel of GPs and a vaccine expert will outline key issues in primary care, relevant pneumococcal serotypes in Australia and considerations when choosing from vaccines that are now available. Finally, a lively panel Q&A will leave you with practical tips for the optimal prevention of this disease in your at-risk patients.

Pages

RELX Group plc